DisclosureWe earn commission on partner links; ranking is set by our evidence-based methodology — not advertisers. Read policy
By HealthVetted Editorial
Reviewed & updated
*Disclosure: HealthVetted is an affiliate-supported publisher and we earn commissions from links on this page. Commissions never change our rankings, ratings, or the evidence we cite. This is editorial content from HealthVetted Editorial and is not medical advice.*
Alli (orlistat 60 mg) is, as of this writing, the only weight-loss pill the FDA has approved for over-the-counter sale in the United States. It works by blocking your gut from absorbing some of the fat you eat, and in a one-year placebo-controlled trial it produced about 8.5% loss of starting body weight versus 5.4% on placebo. It is real, FDA-reviewed, and modest — not a fat-burner and not a GLP-1. Expect single-digit percentage weight loss when paired with a reduced-calorie, lower-fat diet, plus well-documented digestive side effects if you eat fatty meals. This review explains how Alli works, what the evidence actually shows, the honest side-effect picture, who it fits, and how it compares to supplements and prescription options.
Alli is the 60 mg over-the-counter version of orlistat, a lipase inhibitor. It is the only nonprescription weight-loss drug the FDA has approved — every other OTC "diet pill" on shelves is a dietary supplement, which the FDA does not review for safety or effectiveness before sale.
The FDA approved the 60 mg OTC dose (Alli) in 2007; the 120 mg prescription version (Xenical, NDA #021887) was first approved in 1999, per [FDA labeling records](www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021887s000_MedR_P2.pdf). That regulatory review is the single most important thing separating Alli from the supplement aisle.
This matters because most products marketed for weight loss are supplements with limited or insufficient evidence. If you want the difference spelled out, see our guide to [OTC vs prescription weight-loss options](/otc-vs-prescription-weight-loss). Alli is the rare bridge: bought without a prescription, but reviewed like a drug.
Orlistat blocks fat digestion in your gut. It does not suppress appetite, raise metabolism, or "burn" anything — it simply stops some dietary fat from being absorbed, so those calories pass out of the body instead.
Mechanically, orlistat reversibly inhibits gastric and pancreatic lipases, the enzymes that break triglycerides into absorbable fatty acids. According to [StatPearls (NCBI Bookshelf)](www.ncbi.nlm.nih.gov/books/NBK542202), at the 120 mg prescription dose it reduces dietary fat absorption by about 30%. The OTC 60 mg dose blocks somewhat less.
A key consequence: orlistat only works on the fat you eat. Take it with a fat-free meal and it does little; take it with a greasy meal and you get both more blocked fat and more side effects. It acts locally in the gut and is minimally absorbed into the bloodstream.
Modest amounts. In trials, orlistat plus a reduced-calorie diet produced roughly 5–10% loss of starting body weight over a year — only a few percentage points more than diet and placebo alone.
The most-cited evidence: in a one-year randomized, placebo-controlled trial, orlistat-treated patients lost an average of 8.5% of initial body weight versus 5.4% for placebo, and a larger share reached at least 10% loss ([PubMed-indexed RCT](pubmed.ncbi.nlm.nih.gov/10599349)). Trials of the lower OTC dose likewise found it produces modest weight loss above diet alone.
[Mayo Clinic](www.mayoclinic.org/healthy-lifestyle/weight-loss/in-depth/alli/art-20047908) frames it plainly: Alli can help you lose somewhat more weight than diet and exercise alone, but the difference is small and only holds if you keep up the lifestyle changes. The honest takeaway: Alli is a helper, not a solution. Most of the work is still diet and activity.
The side effects are mostly gastrointestinal and directly tied to how it works: unabsorbed fat has to go somewhere. Common effects include oily stools, oily spotting, gas with discharge, urgent bowel movements, and more frequent, loose stools.
Per [StatPearls (NCBI Bookshelf)](www.ncbi.nlm.nih.gov/books/NBK542202), these effects stem from the drug's local action blocking fat digestion — and they tend to worsen the more fat you eat. They are, in effect, built-in feedback: a high-fat meal often produces uncomfortable results, which is partly why the diet change is unavoidable.
Two things to manage carefully:
Yes — several interactions are clinically important, which is why a clinician check-in matters before starting. Because orlistat changes fat absorption, it can affect how some drugs are absorbed.
Orlistat labeling flags these specifically:
These are drawn from [FDA-approved orlistat labeling](dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f81dfaeb-46d5-47ce-9ef6-19259f5ac61c). If you take any prescription medication — or have gallbladder, kidney, thyroid, or malabsorption conditions — confirm with a licensed clinician that Alli is appropriate for you.
Alli may suit motivated adults with overweight or obesity who already plan to follow a reduced-calorie, lower-fat diet and want a modest, FDA-reviewed option they can buy without a prescription. The label is intended for adults 18 and older with a BMI of 25 or higher.
It is a reasonable fit if you:
It is likely a poor fit if you:
For a broader view of evidence-graded options across the category, see our roundup of the [best weight-loss supplements](/best-weight-loss), where we rate products by strength of evidence rather than marketing.
Alli sits between unproven supplements and far more powerful prescription drugs. It is more evidence-backed than typical supplements but produces much smaller weight loss than GLP-1 medications.
Here is the honest hierarchy of effect, with sources:
So the trade-offs are clear. Supplements are easy to buy but mostly under-evidenced. GLP-1s are dramatically more effective but require a prescription, cost more, and carry their own side-effect profile. Alli is the middle path: real evidence, no prescription, modest results, and digestive side effects you largely control through diet.
Alli is legitimate. It is the only FDA-approved OTC weight-loss pill as of this writing, its mechanism is well understood, and its modest benefit is supported by real clinical trials rather than testimonials. But "modest" is the operative word — expect single-digit percentage loss, not transformation, and only if you change how you eat.
If you want a non-prescription option with genuine regulatory backing and you can commit to a lower-fat diet, Alli is a reasonable, honest choice. If you need substantially more weight loss, the evidence points toward prescription GLP-1 therapy discussed with a clinician. Either way, talk to a licensed healthcare provider before starting, especially if you take other medications.
*This article is for general education and is not medical advice. Decisions about weight-loss medications should be made with a licensed clinician who knows your health history.*
Yes. Alli is the 60 mg over-the-counter version of orlistat, approved by the FDA for nonprescription sale in 2007. The 120 mg prescription version (Xenical) was approved in 1999. As of this writing it is the only OTC weight-loss drug the FDA has approved; other OTC diet products are supplements, which are not FDA-approved before sale.
In a one-year randomized, placebo-controlled trial, orlistat users lost an average of about 8.5% of starting body weight versus about 5.4% for placebo — a modest difference of a few percentage points. Results depend heavily on sustained reduced-calorie, lower-fat eating and activity. It is a helper alongside diet, not a stand-alone solution.
The most common effects are gastrointestinal: oily spotting, gas with discharge, loose or oily stools, and urgent bowel movements. They are caused by unabsorbed fat passing through the gut and tend to get worse with high-fat meals. Eating less fat both improves results and reduces these effects.
Yes. Because orlistat reduces absorption of fat-soluble vitamins A, D, E, and K, the FDA label recommends a daily multivitamin containing them (and beta-carotene). Take it at bedtime, at least two hours apart from a dose of orlistat, so the supplement is absorbed properly.
Alli produces modest, single-digit percentage weight loss, while GLP-1 medications are far more effective: semaglutide 2.4 mg averaged about 14.9% body-weight loss over 68 weeks in the STEP 1 trial, and tirzepatide reached about 20.9% at 15 mg in SURMOUNT-1. GLP-1s require a prescription, cost more, and carry their own side-effect profile. Discuss options with a licensed clinician.